Aruni Bhatnagar Selected Research

2-nonenal

1/2020	Cardiospecific Overexpression of ATPGD1 (Carnosine Synthase) Increases Histidine Dipeptide Levels and Prevents Myocardial Ischemia Reperfusion Injury.
4/2006	Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells.
8/2002	Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aruni Bhatnagar Research Topics

Disease

36	Inflammation (Inflammations) 01/2021 - 02/2003
30	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2006
15	Insulin Resistance 01/2019 - 02/2009
13	Atherosclerosis 01/2019 - 02/2003
11	Myocardial Infarction 01/2021 - 06/2008
11	Ischemia 01/2020 - 04/2008
11	Obesity 11/2018 - 07/2009
9	Infarction (Infarctions) 01/2019 - 08/2002
8	Diabetes Complications 09/2021 - 10/2002
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 08/2010
7	Reperfusion Injury 01/2022 - 11/2008
7	Hypertension (High Blood Pressure) 01/2021 - 09/2006
6	Hyperglycemia 09/2021 - 07/2002
6	Type 2 Diabetes Mellitus (MODY) 01/2019 - 02/2013
6	Vascular System Injuries 01/2018 - 08/2003
5	Neoplasms (Cancer) 12/2021 - 01/2003
5	Heart Failure 01/2021 - 11/2011
5	Peritonitis 02/2016 - 02/2013
4	Hypertrophy 01/2018 - 05/2010
4	Sepsis (Septicemia) 03/2017 - 10/2006
4	Thrombosis (Thrombus) 01/2017 - 07/2008
4	Atherosclerotic Plaque (Atheroma) 01/2017 - 04/2009
4	Body Weight (Weight, Body) 06/2015 - 05/2004
4	Necrosis 05/2015 - 03/2012
4	Dyslipidemias (Dyslipidemia) 09/2011 - 07/2009
3	Carcinogenesis 01/2021 - 01/2015
3	Cardiotoxicity 12/2019 - 01/2003
3	Glucose Intolerance 01/2019 - 12/2016
3	Non-alcoholic Fatty Liver Disease 11/2018 - 02/2009
3	Cardiomyopathies (Cardiomyopathy) 01/2016 - 10/2006
3	Left Ventricular Dysfunction 10/2014 - 05/2013
2	Hyperemia 01/2021 - 01/2019
2	Edema (Dropsy) 01/2019 - 11/2009
2	Pain (Aches) 01/2019 - 02/2014
2	Cardiomegaly (Heart Hypertrophy) 01/2018 - 04/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 01/2015
2	Lung Neoplasms (Lung Cancer) 01/2016 - 01/2015

Drug/Important Bio-Agent (IBA)

23	Acrolein (Aqualin)IBA 01/2022 - 08/2003
19	AldehydesIBA 01/2022 - 01/2003
14	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 07/2002
12	Proteins (Proteins, Gene)FDA Link 06/2019 - 05/2004
12	LipidsIBA 08/2016 - 02/2009
11	Particulate MatterIBA 01/2022 - 06/2010
9	Aldehyde Reductase (Aldose Reductase)IBA 06/2019 - 10/2002
8	SmokeIBA 01/2019 - 07/2008
8	CytokinesIBA 01/2019 - 02/2003
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2014
7	Insulin (Novolin)FDA Link 01/2019 - 04/2008
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 02/2003
7	EnzymesIBA 06/2015 - 03/2003
7	Environmental Pollutants (Pollutants, Environmental)IBA 08/2014 - 09/2006
6	polyolIBA 09/2021 - 10/2002
6	C-Reactive ProteinIBA 01/2021 - 11/2015
6	Lipoproteins (Lipoprotein)IBA 01/2019 - 07/2009
5	CarnosineIBA 01/2021 - 06/2013
4	CatecholaminesIBA 01/2021 - 12/2007
4	Glutathione Transferase (Glutathione S-Transferase)IBA 11/2018 - 08/2011
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 10/2012
4	CholesterolIBA 05/2017 - 09/2006
4	AntioxidantsIBA 12/2016 - 05/2004
3	Benzene (Benzole)IBA 11/2021 - 01/2017
3	Sorbitol (Yal)FDA Link 09/2021 - 08/2002
3	HDL LipoproteinsIBA 01/2021 - 07/2009
3	Nicotine FDA Link 10/2020 - 01/2019
3	2-nonenalIBA 01/2020 - 08/2002
3	resolvin D1IBA 12/2019 - 07/2011
3	Drinking WaterIBA 06/2019 - 01/2019
3	sorbinilIBA 06/2019 - 08/2002
3	Superoxide DismutaseIBA 01/2019 - 11/2012
3	Glutathione (Reduced Glutathione)IBA 11/2018 - 10/2006
3	erucylphosphocholineIBA 01/2018 - 07/2010
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2016 - 11/2011
3	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2015
3	Transcription Factors (Transcription Factor)IBA 10/2015 - 08/2002
3	Sulfenic AcidsIBA 03/2012 - 06/2006
3	Triglycerides (Triacylglycerol)IBA 09/2011 - 02/2010
3	tolrestatIBA 04/2008 - 08/2002
3	NF-kappa B (NF-kB)IBA 11/2004 - 08/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 08/2013
2	CotinineIBA 01/2021 - 01/2016
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 12/2018
2	DipeptidesIBA 01/2020 - 06/2013
2	Histidine (L-Histidine)FDA Link 01/2020 - 06/2013
2	Epinephrine (Adrenaline)FDA LinkGeneric 12/2019 - 12/2018
2	cinnamaldehyde (cinnamic aldehyde)FDA Link 12/2019 - 01/2018
2	Free RadicalsIBA 01/2019 - 08/2015
2	tempolIBA 01/2019 - 12/2016
2	Phosphotransferases (Kinase)IBA 11/2017 - 03/2012
2	CalciumIBA 06/2017 - 02/2013
2	Apolipoproteins E (ApoE)IBA 05/2017 - 04/2011
2	ApolipoproteinsIBA 05/2017 - 06/2013
2	AlbuminsIBA 01/2017 - 11/2009
2	CreatinineIBA 01/2017 - 02/2010
2	Oxygen (Dioxygen)IBA 01/2017 - 08/2015
2	Phospholipids (Phosphatides)FDA LinkGeneric 07/2016 - 12/2011

Therapy/Procedure

6	Therapeutics 02/2016 - 07/2009
4	Transplantation 01/2016 - 05/2013
3	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2018 - 10/2014
3	Ligation 02/2016 - 04/2008
2	Lasers (Laser) 08/2016 - 06/2006